6-5260703-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020408.6(LYRM4):​c.31T>G​(p.Ser11Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.277 in 1,553,322 control chromosomes in the GnomAD database, including 71,365 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S11S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.41 ( 16762 hom., cov: 32)
Exomes 𝑓: 0.26 ( 54603 hom. )

Consequence

LYRM4
NM_020408.6 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.36

Publications

55 publications found
Variant links:
Genes affected
LYRM4 (HGNC:21365): (LYR motif containing 4) The protein encoded by this gene is found in both mitochondria and the nucleus, where it binds cysteine desulfurase and helps free inorganic sulfur for Fe/S clusters. Disruption of this gene negatively impacts mitochondrial and cytosolic iron homeostasis. [provided by RefSeq, Sep 2016]
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
FARS2 Gene-Disease associations (from GenCC):
  • metabolic disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • combined oxidative phosphorylation defect type 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 77
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.1671281E-5).
BP6
Variant 6-5260703-A-C is Benign according to our data. Variant chr6-5260703-A-C is described in ClinVar as Benign. ClinVar VariationId is 380035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.771 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYRM4NM_020408.6 linkc.31T>G p.Ser11Ala missense_variant Exon 1 of 3 ENST00000330636.9 NP_065141.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYRM4ENST00000330636.9 linkc.31T>G p.Ser11Ala missense_variant Exon 1 of 3 1 NM_020408.6 ENSP00000418787.1

Frequencies

GnomAD3 genomes
AF:
0.406
AC:
61612
AN:
151740
Hom.:
16717
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.778
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.377
Gnomad ASJ
AF:
0.253
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.175
Gnomad FIN
AF:
0.217
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.255
Gnomad OTH
AF:
0.392
GnomAD2 exomes
AF:
0.288
AC:
47290
AN:
164260
AF XY:
0.270
show subpopulations
Gnomad AFR exome
AF:
0.782
Gnomad AMR exome
AF:
0.361
Gnomad ASJ exome
AF:
0.256
Gnomad EAS exome
AF:
0.265
Gnomad FIN exome
AF:
0.212
Gnomad NFE exome
AF:
0.253
Gnomad OTH exome
AF:
0.285
GnomAD4 exome
AF:
0.263
AC:
368480
AN:
1401474
Hom.:
54603
Cov.:
42
AF XY:
0.259
AC XY:
178914
AN XY:
692054
show subpopulations
African (AFR)
AF:
0.802
AC:
25658
AN:
31986
American (AMR)
AF:
0.361
AC:
13266
AN:
36734
Ashkenazi Jewish (ASJ)
AF:
0.259
AC:
6525
AN:
25200
East Asian (EAS)
AF:
0.254
AC:
9355
AN:
36844
South Asian (SAS)
AF:
0.175
AC:
14003
AN:
79896
European-Finnish (FIN)
AF:
0.214
AC:
9602
AN:
44948
Middle Eastern (MID)
AF:
0.335
AC:
1889
AN:
5632
European-Non Finnish (NFE)
AF:
0.251
AC:
271148
AN:
1082052
Other (OTH)
AF:
0.293
AC:
17034
AN:
58182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
14524
29047
43571
58094
72618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9426
18852
28278
37704
47130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.406
AC:
61707
AN:
151848
Hom.:
16762
Cov.:
32
AF XY:
0.398
AC XY:
29525
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.778
AC:
32216
AN:
41412
American (AMR)
AF:
0.377
AC:
5761
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.253
AC:
878
AN:
3468
East Asian (EAS)
AF:
0.262
AC:
1340
AN:
5120
South Asian (SAS)
AF:
0.174
AC:
833
AN:
4796
European-Finnish (FIN)
AF:
0.217
AC:
2292
AN:
10550
Middle Eastern (MID)
AF:
0.384
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
0.255
AC:
17315
AN:
67910
Other (OTH)
AF:
0.388
AC:
818
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1485
2971
4456
5942
7427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.300
Hom.:
29165
Bravo
AF:
0.438
TwinsUK
AF:
0.258
AC:
957
ALSPAC
AF:
0.248
AC:
956
ESP6500AA
AF:
0.738
AC:
3199
ESP6500EA
AF:
0.249
AC:
2111
ExAC
AF:
0.220
AC:
23291
Asia WGS
AF:
0.257
AC:
896
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 20, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
Jan 13, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Combined oxidative phosphorylation deficiency 19 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Benign
0.092
T;.;T;T;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.0047
N
LIST_S2
Benign
0.046
T;T;T;T;T
MetaRNN
Benign
0.000012
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
.;.;.;.;.
PhyloP100
1.4
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.7
N;N;N;N;N
REVEL
Benign
0.093
Sift
Benign
0.32
T;T;T;T;T
Sift4G
Benign
0.15
T;T;T;T;D
Vest4
0.061
ClinPred
0.035
T
GERP RS
4.2
PromoterAI
-0.028
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.34
gMVP
0.030
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2224391; hg19: chr6-5260936; COSMIC: COSV51166411; COSMIC: COSV51166411; API